3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Melanoma
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Myeloid, Chronic-Phase
3
Polycythemia Vera
2
Neoplasm Metastasis
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Recurrence
1
Primary Myelofibrosis
1
Osteosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms
1
Metastatic Gastrointestinal Carcinoid Tumor
1
Lymphoma, Non-Hodgkin
1
Leukemia-Lymphoma, Adult T-Cell
1
Leukemia
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Graft vs Host Disease
1
Glioma
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Interventions
fludarabine phosphate
38
Cyclophosphamide
37
Peripheral Blood Stem Cell Transplantation
32
Busulfan
28
Tacrolimus
26
Whole-Body Irradiation
20
Mycophenolic Acid
19
Methotrexate
17
Antilymphocyte Serum
17
ruxolitinib
16
fludarabine
14
Filgrastim
13
Cyclosporine
12
Melphalan
11
Radiotherapy
9
Etoposide
9
thymoglobulin
8
Psychiatric Rehabilitation
8
Prednisone
8
Methylprednisolone
8
Cytarabine
6
Cord Blood Stem Cell Transplantation
6
Thiotepa
5
Sirolimus
5
Imatinib Mesylate
5
Flow Cytometry
5
Azacitidine
5
Alemtuzumab
5
sargramostim
4
merphos
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Primary Myelofibrosis
×
peginterferon alfa-2b
×
Clear all
NCT01387763
2022-04-27
DALIAH
Odense University Hospital
Phase 3
Completed
202 enrolled